- Dec 29 Mon 2014 06:03
OTC Markets Group Welcomes Castle Mountain Mining to OTCQX®
- Dec 29 Mon 2014 06:01
Early findings of Harvard, Northeastern research show organic's benefits
- Dec 29 Mon 2014 06:00
The Seleni Institute Announces New Clinical Director
- Dec 29 Mon 2014 05:59
SEC targets Wyly relatives in effort to collect $300 million claim
The U.S. and Securities Exchange Commission on Tuesday added more than a dozen relatives of Texas businessmen Sam and Charles Wyly to a long-running securities fraud lawsuit against the brothers to bolster its efforts to collect some $300 million.
The amended complaint filed in New York federal court included the relatives as "relief defendants," which means they are not accused of wrongdoing but can be subject to civil claims.
- Dec 29 Mon 2014 05:58
GLOBAL MARKETS-Bonds rally, stocks fall as global economy fears mount
Stocks took a pounding on
Wednesday, although Wall Street managed to peddle back from its
- Dec 29 Mon 2014 05:57
Premune Names Carl K. Johnson Chief Medical Officer
NEW YORK, Aug. 20, 2014 (GLOBE NEWSWIRE) -- Premune, a development stage biopharmaceutical company focused on developing novel treatments for allergies and autoimmune-related disorders in companion animals, today announced the appointment of Dr. Carl K. Johnson, D.V.M. as Chief Medical Officer. Johnson, who will be based in Premune's New York office and report directly to CEO Viktor Karlsson, will be responsible for leading Premune's global product development initiatives. Johnson is the most recent senior-level hire since the Company announced the establishment of its U.S. office on April 15, 2014.
- Dec 29 Mon 2014 05:56
Ball Aerospace Wins NASA Earth Science HAWC-OAWL Research and Development Contract
